Day One Biopharmaceuticals, Inc.
DAWN
$9.73
$0.748.23%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 17.36% | 10.23% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 17.36% | 10.23% | |||
| Cost of Revenue | 18.99% | 30.55% | |||
| Gross Profit | 17.16% | 8.13% | |||
| SG&A Expenses | -2.83% | -1.22% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -7.02% | -4.10% | |||
| Operating Income | 30.66% | 14.84% | |||
| Income Before Tax | 34.94% | 15.76% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 34.94% | 15.76% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 34.94% | 15.76% | |||
| EBIT | 30.66% | 14.84% | |||
| EBITDA | 31.45% | 15.31% | |||
| EPS Basic | 35.15% | 16.06% | |||
| Normalized Basic EPS | 35.13% | 16.03% | |||
| EPS Diluted | 35.15% | 16.06% | |||
| Normalized Diluted EPS | 35.13% | 16.03% | |||
| Average Basic Shares Outstanding | 0.30% | 0.35% | |||
| Average Diluted Shares Outstanding | 0.30% | 0.35% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||